Physician profile
Mitchell E Lyons
NPI 1043716251
$2,118.55
in general payments reported to CMS, 2019-2025
13 companies · $657 in 2025
The $657 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $17.81 · 2024: $1,444 · 2025: $657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,671 · Travel and Lodging: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,670.70 |
| Travel and Lodging | $447.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,290.72 | 2024-2025 | |
| Motiva USA, LLC | $219.90 | 2025 | |
| Mentor Worldwide LLC | $156.82 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Axogen | $103.03 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Musculoskeletal Transplant Foundation INC. | $96.66 | 2025 | |
| Leo Pharma INC. | $48.61 | 2025 | Anzupgo |
| Janssen Biotech, INC. | $41.22 | 2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $33.95 | 2025 | Sotyktu |
| Ucb, INC. | $32.30 | 2025 | Bimzelx |
| Stryker Corporation | $31.36 | 2023-2024 | Core, N/A |
| Sun Pharmaceutical Industries INC. | $25.47 | 2025 | |
| Lilly USA, LLC | $19.28 | 2025 | Ebglyss, Taltz |
| Smith+Nephew, INC. | $19.23 | 2024 | Stravix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.